Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A Janitor from California

At our fiscal 2009 Annual Meeting of Shareholders held on January 28, 2010, the following individuals were elected to the Board of Directors of the Company: Carlton M. Johnson, Jr., Helmut Falk, Jr., Gloria H. Felcyn, Donald E. Schrock and Dharmesh Mistry.


2. Election of Directors:

Director
Votes For
Votes Abstaining
and/or Against
Carlton M. Johnson, Jr.
47,635,901
43,155,665
Helmut Falk, Jr.
48,915,455
41,876,111
Gloria H. Felcyn
48,582,583
42,208,983
Donald E. Schrock
67,649,501
23,100,290
Dharmesh Mistry
71,319,001
19,472,565


There were about 335M voting shares for the "Proposal to ratify management’s selection of KMJ Corbin & Company LLP as our independent auditors:"

Votes For
Votes Against
Votes Abstaining
302,021,274
26,789,475
5,508,620

So you figure there were roughly 245M that didn't vote for the BoD election, most likely broker votes. Because:
On July 1, 2009, the SEC approved a proposal prohibiting discretionary voting by brokers of shares held by their customers in street name in uncontested elections of directors effective for shareholder meetings beginning in 2010. Brokers may continue to vote as they wish on routine matters (such as ratification of auditors) on behalf of their beneficial owner customers provided the customer has not given specific voting instructions to the broker at least 10 days before a scheduled meeting.

The results of the SEC’s July 2009 action are reflected in the difference between voting totals for our ratification of auditors proposal as compared to the voting totals for our election of directors proposal.

Bottom line, most voting shares don't care.


Share
New Message
Please login to post a reply